Vidarbha News

Frontotemporal Dementia Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, MOA, ROA by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics Inc, Passage Bio

Frontotemporal Dementia Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, MOA, ROA by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics Inc, Passage Bio

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Frontotemporal Dementia pipeline constitutes 25+ key companies continuously working towards developing 25+ Frontotemporal Dementia treatment therapies, analysis of Clinical Trials,

Read Full Article

Gastric Neuroendocrine Tumors Market and Epidemiology Forecast 2032: Population Data, Drugs, Companies and Competitive Intelligence by DelveInsight | Ipsen, Taproot Health, Camurus AB, Novartis

The Gastric Neuroendocrine Tumors market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize

Read Full Article

Heparin Induced Thrombocytopenia Market to Witness Growth by 2032, Estimates DelveInsight | Mitsubishi Tanabe Pharma, Veralox Therapeutics, The Medicines Company, Canyon Pharma

The Heparin-induced Thrombocytopenia market size was valued approximately USD 125 million in 2022 and is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period.

Read Full Article

Glaucoma Market to Observe Impressive Growth During the Forecast Period (2024-2034), Evaluates DelveInsight | Bayer, SPARC, Laboratories Sophia, Santen Pharmaceutical, Nicox Ophthalmics, Ocuphire

The Glaucoma Market size was valued approximately USD 4,073 million in 2022 and report offers an in-depth understanding of the Glaucoma, historical and forecasted epidemiology as well as the Glaucoma

Read Full Article

Gastroesophageal Reflux Disease Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Phantom Pharmaceuticals, Sinorda Biomed

The Gastroesophageal Reflux Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gastroesophageal Reflux Disease pipeline products

Read Full Article

Inflammatory Bowel Disease Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Eli Lilly and Company, Gilead, Galapagos, Applied Molecular Transport

The Inflammatory Bowel Disease Market Forecast and Insights report offers an in-depth understanding of the Inflammatory Bowel Disease, historical and forecasted epidemiology as well as the Inflammatory Bowel Disease market

Read Full Article

Ischemia Reperfusion Injury Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Dompé Farmaceutici, Stealth BioTherapeutics, ICON Clinical

The Ischemia Reperfusion Injury market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize

Read Full Article

Ischemic Stroke Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, Abbvie

The Ischemic Stroke market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Ischemic Stroke pipeline products will significantly

Read Full Article

Kidney Transplant Rejection Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Medeor Therapeutics, Talaris Therapeutics, CSL Behring, Eledon Pharma

The Kidney Transplant Rejection Market Forecast and Insights report offers an in-depth understanding of the Kidney Transplant Rejection, historical and

Read Full Article

Lewy Body Dementia Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Eisai, EIP Pharma, Sun Pharma, Axovant Sciences Ltd., Cognition

The Lewy Body Dementia Market Forecast and Insights report offers an in-depth understanding of the Lewy Body Dementia, historical and

Read Full Article

Schneider Electric and NVIDIA’s collaborative masterplan

Schneider Electric has teamed up with NVIDIA to launch AI data centre reference designs, aiming to enhance the implementation of

Read Full Article

Schneider Electric strengthens India’s role in global data center supply with new Bangalore factory

Schneider Electric, a leader in the digital transformation of energy management and automation, has inaugurated a new cooling factory in

Read Full Article

Schneider Electric Begins Innovation Summit World Tour, Unveiling Latest Innovations and Collaborations

Schneider Electric, the leader in the digital transformation of energy management and automation, today kicked off its Innovation Summit World

Read Full Article

Schneider Electric plans to invest ₹3,200 crore in India

Schneider Electric aims to add 6,500 employees to its existing workforce by 2026, says Executive VP, Global Home & Distribution,

Read Full Article

Schneider Electric, Nvidia partner to optimise data centre infrastructure

Energy management and automation major Schneider Electric on Thursday said it has collaborated with NVIDIA to optimise data center infrastructure.

Read Full Article

Gout Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | AstraZeneca, R-Pharm, Allena Pharma, JW Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Gout pipeline constitutes 40+ key companies continuously working towards developing

Read Full Article

Epilepsy Market to Register Incremental Growth During the Forecast Period (2023-2032), Analyses DelveInsight | Neurocrine Bioscience, Takeda, Ovid Therapeutics, UCB Biopharma, Zynerba

Epilepsy Market (Albany, USA) DelveInsight’s “Epilepsy Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Epilepsy, historical and forecasted

Read Full Article

Optometry Equipment Market worth $6.1 billion by 2029

Browse in-depth TOC on “Optometry Equipment Market” 321 – Tables 43 – Figures 290 – Pages Browse 321 market data

Read Full Article

Monoclonal Antibody (mABs) Therapeutics Market worth $497.5 billion by 2029

Browse 365 market data Tables and 58 Figures spread through 350 Pages and in-depth TOC on “Monoclonal Antibody (mABs) Therapeutics

Read Full Article

Laser Capture Microdissection Market worth $306 million by 2029

Browse in-depth TOC on “Laser Capture Microdissection Market” 139 – Tables 40 – Figures 193 – Pages Laser Capture Microdissection

Read Full Article

Categories